Patel Chintu's Form 4 filing
Amneal Pharmaceuticals, Inc. (AMRX) · filed Dec 17, 2021
- Accession no.
- 0001209191-21-070258
- Filed
- Dec 17, 2021
- Trade date
- Dec 15-16, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $625.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel ChintuCIK 0001737428 | Director, Officer (Co-CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2021 | Class A Common Stock | PPurchaseAcquired | +100,000 | $4.13 | +$413,000 | 462,566 | Direct | |
| Dec 16, 2021 | Class A Common Stock | PPurchaseAcquired | +50,000 | $4.25 | +$212,500 | 512,566 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.